Pre-specified secondary analysis of a cluster trial at 28 facilities in Mozambique and Tanzania: point-of-care HIV testing at birth raised ART start within a week by 90.0 and 59.9 percentage points, at ICERs of $2,924 and $10,458; unlikely cost-effective at standard thresholds.
Secondary analysisn = 28 facilities
Elsbernd et al. Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study